The Asia-Pacific immunochemistry market is expected to reach US$ 795.05 Mn in 2027 from US$ 436.79 Mn in 2019. The market is estimated to grow with a CAGR of 7.8% from 2019-2027.
The growth of the market is driven by the factors such as, rising incidences of chronic and infectious diseases and increasing geriatric population. However, the market is likely to slower down its growth due to the limitations associated with immunohistochemistry.
The countries in the region are creating significant opportunities for the key market players to expand their business. It is likely to be a major factor contributing to the market growth during the coming years. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry and geographic scope.
Also, the rising advancements in the biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of a more significant number of immunoassay systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in a developing nation.
The increasing investments in R&D activities have paved the way for the growth of the industry in the future years. Many scientists, in partnership with other scientists in China, offer various products for bioreactors. For instance, in April 2018, BIO attended meetings with members of the Chinese biotech community and government leaders. The conference aims the commitment on behalf of the western biotechnology industry for encouraging China to strengthen its support for biotech innovation. They aim to and take steps to enhance more significant investment and collaboration with companies in China. Thus, the rising number of infectious disease incidences and advancements are likely to boost the market and are anticipated to provide significant growth opportunities to the players operating in the Immunochemistry Equipment Market during the forecast period.
The China is expected to lead the market in the Asia-Pacific region owing to the rapidly increasing incidence of chronic diseases like cancer in the country and the growing demand for diagnostics. Furthermore, the increasing prevalence of diabetes is also likely to grow the Immunochemistry Equipment Market. Therefore, considering the above-mentioned factors, the growth of the market in the country is expected to contribute the largest share in the Asia-Pacific region during the forecast period.
ASIA-PACIFICIMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION
Asia-Pacific immunochemistry market Equipment Market - By Product
Asia-Pacific immunochemistry market Equipment Market - By Application
Asia-Pacific immunochemistry market Equipment Market - By End User
Asia-Pacific immunochemistry market Equipment Market - By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 436.79 Million |
| Market Size by 2027 | US$ 795.05 Million |
| CAGR (2019 - 2027) | 7.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Application
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
The Asia Pacific Immunochemistry Equipment Market is valued at US$ 436.79 Million in 2019, it is projected to reach US$ 795.05 Million by 2027.
As per our report Asia Pacific Immunochemistry Equipment Market, the market size is valued at US$ 436.79 Million in 2019, projecting it to reach US$ 795.05 Million by 2027. This translates to a CAGR of approximately 7.8% during the forecast period.
The Asia Pacific Immunochemistry Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Immunochemistry Equipment Market report:
The Asia Pacific Immunochemistry Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Immunochemistry Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Immunochemistry Equipment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Immunochemistry Equipment Market
